FDA to remove boxed warnings from hormone therapies for menopause
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingPharmaceuticalsPublic healthRegulatory Intelligence/PolicyRegulatory strategyUnited StatesUS Food and Drug Administration (FDA)